21 related articles for article (PubMed ID: 21469979)
1. Structural and genic characterization of stable genomic regions in breast cancer: relevance to chemotherapy.
Park NI; Rogan PK; Tarnowski HE; Knoll JH
Mol Oncol; 2012 Jun; 6(3):347-59. PubMed ID: 22342187
[TBL] [Abstract][Full Text] [Related]
2. Recruitment of Tiam1 to Semaphorin 4D Activates Rac and Enhances Proliferation, Invasion, and Metastasis in Oral Squamous Cell Carcinoma.
Zhou H; Kann MG; Mallory EK; Yang YH; Bugshan A; Binmadi NO; Basile JR
Neoplasia; 2017 Feb; 19(2):65-74. PubMed ID: 28038319
[TBL] [Abstract][Full Text] [Related]
3. ERK/MAPK regulates ERRγ expression, transcriptional activity and receptor-mediated tamoxifen resistance in ER+ breast cancer.
Heckler MM; Thakor H; Schafer CC; Riggins RB
FEBS J; 2014 May; 281(10):2431-42. PubMed ID: 24684682
[TBL] [Abstract][Full Text] [Related]
4. Biological resonance for cancer metastasis, a new hypothesis based on comparisons between primary cancers and metastases.
Gao D; Li S
Cancer Microenviron; 2013 Dec; 6(3):213-30. PubMed ID: 24214411
[TBL] [Abstract][Full Text] [Related]
5. Differential copy number aberrations in novel candidate genes associated with progression from in situ to invasive ductal carcinoma of the breast.
Liao S; Desouki MM; Gaile DP; Shepherd L; Nowak NJ; Conroy J; Barry WT; Geradts J
Genes Chromosomes Cancer; 2012 Dec; 51(12):1067-78. PubMed ID: 22887771
[TBL] [Abstract][Full Text] [Related]
6. Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study.
Wang C; Iakovlev VV; Wong V; Leung S; Warren K; Iakovleva G; Arneson NC; Pintilie M; Miller N; Youngson B; McCready DR; Done SJ
Genes Chromosomes Cancer; 2009 Dec; 48(12):1091-101. PubMed ID: 19760610
[TBL] [Abstract][Full Text] [Related]
7. Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases.
Torres L; Ribeiro FR; Pandis N; Andersen JA; Heim S; Teixeira MR
Breast Cancer Res Treat; 2007 Apr; 102(2):143-55. PubMed ID: 16906480
[TBL] [Abstract][Full Text] [Related]
8. High-resolution genomic profiling to predict 10-year overall survival in node-negative breast cancer.
Möllerström E; Delle U; Danielsson A; Parris T; Olsson B; Karlsson P; Helou K
Cancer Genet Cytogenet; 2010 Apr; 198(2):79-89. PubMed ID: 20362222
[TBL] [Abstract][Full Text] [Related]
9. Microarray comparative genomic hybridization analysis of tubular breast carcinoma shows recurrent loss of the CDH13 locus on 16q.
Riener MO; Nikolopoulos E; Herr A; Wild PJ; Hausmann M; Wiech T; Orlowska-Volk M; Lassmann S; Walch A; Werner M
Hum Pathol; 2008 Nov; 39(11):1621-9. PubMed ID: 18656243
[TBL] [Abstract][Full Text] [Related]
10. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.
Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C
Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936
[TBL] [Abstract][Full Text] [Related]
11. The genomic relationship between primary breast carcinomas and their nodal metastases.
Desouki MM; Liao S; Conroy J; Nowak NJ; Shepherd L; Gaile DP; Geradts J
Cancer Invest; 2011 May; 29(4):300-7. PubMed ID: 21469979
[TBL] [Abstract][Full Text] [Related]
12. Hard-wired genotype in metastatic breast cancer.
Weigelt B; van't Veer LJ
Cell Cycle; 2004 Jun; 3(6):756-7. PubMed ID: 15153810
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
